Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
Clinical trial NCT02794883 · COMPLETED
Trial details
- NCT number
- NCT02794883
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-05-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.